TimesSquare Capital Management's U.S. Small Cap Growth Strategy had a 5.77% return in the first quarter of 2024, slightly below the Russell 2000 Growth Index. They highlighted RAPT Therapeutics, Inc. as a top pick, despite its recent stock performance.